台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    84.9
  • 漲跌
    ▲0.4
  • 漲幅
    +0.47%
  • 成交量
    471
  • 產業
    上櫃 生技醫療類股
  • 318人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
中裕 (4147)籌碼相關-元大-土城學府 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-土城學府 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/080.4100.5000.0097.200.48720.05%
2025/01/0300.000.487.7088.30-0.4600-0.06%
2024/12/3000.00086.0085.5005930.00%
2024/12/2700.000.186.5085.80-0.1593-0.01%
2024/12/1300.00084.0083.0006270.00%
2024/11/2900.00284.5584.30-2524-0.38%
2024/11/2200.00180.5079.90-1512-0.20%
2024/11/20178.2000.0079.0015150.19%
2024/11/1400.00181.0081.00-1536-0.19%
2024/10/2400.00180.9080.80-1572-0.17%
2024/10/2300.00182.1081.80-1570-0.18%
2024/10/2200.00379.7380.60-3562-0.53%
2024/10/18174.9000.0073.6015840.17%
2024/10/11074.9000.0074.7006190.00%
2024/10/07177.5000.0077.8016290.16%
2024/10/01179.5000.0079.4016350.16%
2024/09/27180.2000.0080.1016490.15%
2024/09/19081.1000.0080.7006480.00%
2024/09/1800.00180.4081.40-1665-0.15%
2024/09/13179.4000.0079.3016720.15%
2024/09/0400.00282.0081.30-2742-0.27%
2024/09/03183.7000.0084.0017510.13%
2024/08/3000.00286.3586.40-2750-0.27%
2024/08/2700.00182.3082.00-1739-0.14%
2024/07/29284.9000.0082.6027410.27%
2024/07/26285.7500.0085.8027350.27%
2024/07/2200.00288.2087.10-2745-0.27%
2024/07/1900.00189.6086.50-1727-0.14%
2024/07/1700.00188.1088.10-1713-0.14%
2024/07/08186.5000.0086.0018290.12%
2024/07/05186.9000.0086.8018560.12%
2024/07/04187.3000.0086.9018890.11%
2024/06/2600.00189.4089.50-11,123-0.09%
2024/06/24187.4000.0086.7011,1280.09%
2024/06/21288.6500.0088.9021,1210.18%
2024/06/11292.35392.0791.00-11,182-0.08%
2024/06/07188.5000.0090.1011,1670.09%
2024/06/0500.00190.5090.30-11,237-0.08%
2024/05/21188.80190.7088.0002,1230.00%
2024/05/1700.00188.5087.70-12,170-0.05%
2024/05/16186.00186.1086.9002,1890.00%
2024/05/1400.00187.5087.40-12,250-0.04%
2024/04/29185.2000.0086.0012,3380.04%
2024/04/19186.60186.2083.1002,3340.00%
2024/04/16188.5000.0087.9012,3510.04%
2024/04/09195.40296.4096.20-12,301-0.04%
2024/04/08190.50190.8093.0002,2360.00%
2024/04/03791.80891.8090.60-12,195-0.05%
2024/03/25188.5000.0087.8012,0270.05%
2024/03/150.390.90191.9090.10-0.71,970-0.03%
2024/03/140.592.5000.0091.700.51,9600.03%
2024/03/13091.5000.0090.9001,9470.00%
2024/03/12093.60191.9091.90-11,944-0.05%
2024/03/08298.05196.8096.8011,8650.05%
2024/03/071103.0000.00107.5011,7970.06%
2024/03/051109.003103.83102.50-21,704-0.12%
2024/03/040109.0000.00109.0001,6410.00%
2024/03/0100.002109.25109.00-21,602-0.12%
2024/02/291107.5000.00110.5011,5590.06%
2024/02/271112.503113.17114.00-21,413-0.14%
2024/02/263106.832109.50108.0011,2470.08%
2024/02/232103.752102.50102.5001,1070.00%
2024/02/2200.00195.8096.30-11,019-0.10%
2024/02/2000.00494.9596.30-4979-0.41%
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕與沙國藥廠簽抗愛滋病新藥中東、北非獨家銷售合約UDN聯合新聞網-2024/03/14
中裕 相關文章